Viking Global Investors

Activity from announced rounds

All recorded activity
Rounds participated in
4
Confirmed lead rounds
1
3 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$339.5M
4 disclosed · full round size, not this investor’s share

By stage

Series C+2
Series B1
Undisclosed1

By primary sector

Healthtech3
Biotech1

By country

United States4

Rounds

4 in all activity
nPhase

nPhase provides software that connects clinical research data from collection through statistical analysis and regulatory submission.

$30MSeries D
Lead
Pearl Health

Provides an AI platform for healthcare providers to manage risk and improve care for Medicare patients

$110MEquity+Debt
Role not disclosed
GT Medical Technologies

Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors

$100MSeries E
Role not disclosed
City Therapeutics

City Therapeutics develops RNA-interference therapeutics and an engineering platform across disease areas.

$99.5MSeries B
Role not disclosed